A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Multiple Sclerosis and Their Infants
Clinical trial NCT06133049 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06133049
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-03-16
- Primary completion
- 2031-03-31
- Enrollment
- 2961
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.